Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Titre
Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
Sujet
Description
SARS-CoV-2, the coronavirus that causes Covid-19, enters human cells by binding of its viral spike protein to the membrane-bound form of the aminopeptidase angiotensin-converting enzyme 2 (ACE2).
Date
2020-05-01
Type
Citer ce document
Jarcho, John A., Julie R. Ingelfinger, Mary Beth Hamel, Ralph B. D’Agostino, and David P. Harrington. 2020. "Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19." New England Journal of Medicine.
Accessibilité
Free online on NEJM
Was this resource helpful?